Tango Therapeutics (TNGX) Interest & Investment Income (2020 - 2021)

Tango Therapeutics (TNGX) recorded quarterly Interest & Investment Income of $5634.0 in Q2 2021, down 78.87% quarter-over-quarter from $26666.0 in Q1 2021.

Tango Therapeutics (TNGX) Interest & Investment Income (2020 - 2021) Analysis & Trends

Tango Therapeutics' Interest & Investment Income history runs 2 years deep, the most recent figure standing at $5634.0 for Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 597,319.59
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 40.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 305,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 103,341.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 114.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - -14.79 Mn
10 Tango Therapeutics 4.05 Bn 3.67 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 5,634.00
Mar 31, 2021 26,666.00
Dec 31, 2020 65,246.00